SCHEMBL6920152

SCHEMBL6920152

CCCc1nn(C)c(O)c1C(=O)c1cnccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.39
HTT P42858 1/20 0.39
KDM4E B2RXH2 5/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
ALDH1A1 P00352 2/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
NAPRT Q6XQN6 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
TSHR P16473 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
MC4R P32245 1/20 0.36
ADRA1A P35348 1/20 0.36
MC3R P41968 1/20 0.36
MAPT P10636 2/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6919673 0.82 KMT2A (0.41) SMN1; SMN2HTTKDM4ENPC1RAB9A
SCHEMBL2214214 0.80 ALDH1A1 (0.43) HTTALDH1A1HCAR2TSHRMAPT
SCHEMBL6820940 0.79 SMN1; SMN2 (0.35) SMN1; SMN2HTTKDM4ENPC1RAB9A
SCHEMBL6920029 0.76 HCAR2 (0.39) SMN1; SMN2HTTKDM4ENPC1RAB9A
SCHEMBL6921028 0.76 P2RX7 (0.38) SMN1; SMN2HTTKDM4ENPC1RAB9A
SCHEMBL6919835 0.73 L3MBTL1 (0.47) SMN1; SMN2HTTNPC1RAB9AALDH1A1
SCHEMBL6916937 0.73 HCAR2 (0.41) SMN1; SMN2HTTKDM4ENPC1RAB9A
SCHEMBL10753599 0.69 RAB9A (0.44) SMN1; SMN2HTTKDM4ENPC1RAB9A
SCHEMBL6918282 0.68 ALDH1A1 (0.42) SMN1; SMN2HTTNPC1RAB9AALDH1A1
SCHEMBL3186159 0.66 KDM4E (0.70) SMN1; SMN2KDM4ENPC1RAB9ANAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004033431-A2 HYDROXYPYRAZOLES FOR USE AGAINST METABOLIC-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2004-04-22 WO disclosed